ModerateCaution
Fish oil has antiplatelet properties that may add to clopidogrel's platelet inhibition, increasing the overall bleeding risk. While moderate fish oil doses are generally well-tolerated, the additive antiplatelet effect may be clinically significant, especially with other bleeding risk factors.
Recommendation: Use moderate fish oil doses (1-2g/day) cautiously with clopidogrel. Higher doses may increase bleeding risk. Report any unusual bleeding, bruising, or prolonged bleeding from cuts to your healthcare provider.
SeriousCaution
Ginkgo biloba has significant antiplatelet activity (PAF antagonism) that adds to clopidogrel's platelet inhibition, substantially increasing bleeding risk. Case reports have documented serious bleeding events with this combination, including intracerebral hemorrhage.
Recommendation: Avoid ginkgo biloba while taking clopidogrel. The additive antiplatelet effect creates a serious bleeding risk. If you are taking ginkgo, inform your cardiologist and discontinue it.
SeriousCaution
Triple therapy (warfarin + clopidogrel + aspirin) or dual therapy (warfarin + clopidogrel) substantially increases major bleeding risk compared to either agent alone.
Recommendation: Only combine when clearly indicated (e.g., post-PCI with AF). Use the shortest duration possible. Monitor INR more frequently. Consider DOAC instead of warfarin when feasible.
ModerateCaution
Curcumin inhibits platelet aggregation through thromboxane A2 synthesis inhibition and GPVI-mediated platelet activation blockade in laboratory studies. When combined with clopidogrel's P2Y12 receptor-mediated antiplatelet effect, there is theoretical additive bleeding risk through dual-pathway platelet inhibition. However, a clinical study with a bioavailable curcumin formulation (Meriva) found no significant increase in bleeding time in patients on standard-dose clopidogrel after 10 days.
Recommendation: Use caution with concentrated curcumin supplements while on clopidogrel. Culinary turmeric as a spice is generally safe. If using curcumin supplements, inform your prescriber and watch for signs of increased bleeding (easy bruising, prolonged bleeding from cuts, blood in stool or urine). Stop curcumin at least 2 weeks before any planned surgery.
SeriousCaution
St. John's Wort induces CYP3A4 and CYP2C19, which are the key enzymes responsible for converting clopidogrel from its inactive prodrug form to its active metabolite. A clinical study showed that St. John's Wort decreased platelet aggregation and increased platelet inhibition in both clopidogrel hyporesponders and regular patients, effectively enhancing clopidogrel's antiplatelet effect. While this might seem beneficial for hyporesponders, the unpredictable potentiation increases bleeding risk.
Recommendation: Avoid self-prescribing St. John's Wort with clopidogrel. While it may enhance clopidogrel activation, the unpredictable magnitude of increased antiplatelet effect raises bleeding risk. If your prescriber has identified clopidogrel hyporesponsiveness, discuss this potential interaction with them rather than self-managing with St. John's Wort.
ModerateCaution
Garlic supplements inhibit platelet aggregation and have been studied head-to-head with clopidogrel. Combined with clopidogrel's irreversible P2Y12 inhibition, garlic stacks antiplatelet activity and can increase bleeding risk, particularly perioperatively.
Recommendation: Avoid concentrated garlic supplements on clopidogrel. Cooking with garlic is fine. Stop garlic supplements at least 7 days before any planned surgery.
ModerateCaution
Ginger extract inhibits cyclooxygenase and reduces platelet thromboxane A2 generation. Added to clopidogrel's P2Y12 inhibition, ginger supplements stack antiplatelet activity and can increase bleeding risk.
Recommendation: Avoid concentrated ginger extract on clopidogrel. Culinary amounts of ginger in food are fine. Stop ginger supplements at least 7 days before any planned surgery.
DangerousCaution
Nattokinase is a fibrinolytic enzyme that degrades fibrin and reduces clotting factors. Combined with clopidogrel's P2Y12-mediated platelet inhibition, the additive effect substantially raises bleeding risk, especially intracranial bleeding in patients with cerebrovascular disease.
Recommendation: Do not combine nattokinase with clopidogrel. If you have been taking both, stop the nattokinase and contact your prescriber, particularly if you have any history of stroke or unusual bruising or bleeding.
NutriStack